A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 04 Mar 2017
At a glance
- Drugs Tradipitant (Primary)
- Indications Atopic dermatitis; Eczema; Pruritus
- Focus Proof of concept; Therapeutic Use
- Sponsors Vanda Pharmaceuticals
- 28 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Sep 2017.
- 15 Feb 2017 According to a Vanda Pharmaceuticals media release, enrollment in the study is approaching completion and results are expected in mid 2017.
- 27 Jul 2016 According to a Vanda Pharmaceuticals media release, results from this trial are expected in the first half of 2017.